Lista de obras - Sultan Darvesh - Dominio Público Uruguay

1-(3-<i>Tert</i>-Butylphenyl)-2,2,2-Trifluoroethanone as a Potent Transition-State Analogue Slow-Binding Inhibitor of Human Acetylcholinesterase: Kinetic, MD and QM/MM Studies

scientific article published on 27 November 2020

A medical health report on individuals with silent butyrylcholinesterase in the Vysya community of India

artículo científico publicado en 2006

A method to describe enzyme-catalyzed reactions by combining steady state and time course enzyme kinetic parameters

artículo científico publicado en 2010

A versatile equation to describe reversible enzyme inhibition and activation kinetics: modeling beta-galactosidase and butyrylcholinesterase

artículo científico publicado en 2007

An MRI brain atrophy and lesion index to assess the progression of structural changes in Alzheimer's disease, mild cognitive impairment, and normal aging: a follow-up study.

artículo científico publicado en 2011

An MRI-based semiquantitative index for the evaluation of brain atrophy and lesions in Alzheimer's disease, mild cognitive impairment and normal aging

artículo científico publicado en 2010

An integrated proteomics approach shows synaptic plasticity changes in an APP/PS1 Alzheimer's mouse model

artículo científico publicado en 2016

Aryl acylamidase activity of human serum albumin with o-nitrotrifluoroacetanilide as the substrate

artículo científico publicado en 2007

Butyrylcholinesterase Is Associated With β-Amyloid Plaques in the Transgenic APPSWE/PSEN1dE9 Mouse Model of Alzheimer Disease ⬇️

artículo científico publicado el 1 de enero de 2012

Butyrylcholinesterase activity in multiple sclerosis neuropathology.

artículo científico publicado en 2010

Butyrylcholinesterase and the cholinergic system.

artículo científico publicado en 2013

Butyrylcholinesterase as a Diagnostic and Therapeutic Target for Alzheimer's Disease

artículo científico publicado en 2016

Butyrylcholinesterase radioligands to image Alzheimer's disease brain.

artículo científico publicado en 2012

Butyrylcholinesterase-Mediated enhancement of the enzymatic activity of trypsin

artículo científico publicado en 2001

Butyrylcholinesterase-knockout reduces brain deposition of fibrillar β-amyloid in an Alzheimer mouse model.

artículo científico publicado en 2015

Butyrylcholinesterase-knockout reduces fibrillar β-amyloid and conserves 18FDG retention in 5XFAD mouse model of Alzheimer's disease

artículo científico publicado en 2017

Carbamates with differential mechanism of inhibition toward acetylcholinesterase and butyrylcholinesterase.

artículo científico publicado en 2008

Cholinergic Neurons in Nucleus Subputaminalis in Primary Progressive Aphasia

scientific article published on 01 March 2019

Cholinesterase inhibition in Alzheimer's disease: is specificity the answer?

artículo científico publicado en 2014

Cholinesterase inhibitors modify the activity of intrinsic cardiac neurons.

artículo científico publicado en 2004

Cholinesterases in cardiac ganglia and modulation of canine intrinsic cardiac neuronal activity

artículo científico publicado en 1998

Cholinesterases in normal and Alzheimer's disease primary olfactory gyrus.

artículo científico publicado en 2017

Cholinesterases: roles in the brain during health and disease.

artículo científico publicado en 2005

Clock Drawing Test in acute stroke and its relationship with long-term functional and cognitive outcomes

artículo científico publicado en 2018

Comparison of the Binding of Reversible Inhibitors to Human Butyrylcholinesterase and Acetylcholinesterase: A Crystallographic, Kinetic and Calorimetric Study.

artículo científico publicado en 2017

Corticobasal degeneration substantiated by imaging studies.

artículo científico publicado en 2005

Cysteine thioesters as myelin proteolipid protein analogues to examine the role of butyrylcholinesterase in myelin decompaction.

artículo científico publicado en 2010

Development of acetophenone ligands as potential neuroimaging agents for cholinesterases.

artículo científico publicado en 2016

Differential binding of phenothiazine urea derivatives to wild-type human cholinesterases and butyrylcholinesterase mutants.

artículo científico publicado en 2010

Differential effects of lipid-lowering agents on human cholinesterases.

artículo científico publicado en 2004

Disconnection of language and memory in semantic dementia: a comparative and theoretical analysis

artículo científico publicado en 2005

Distribution of Acetylcholinesterase in the Hippocampal Formation of the Atlantic White-sided Dolphin (Lagenorhynchus acutus)

artículo científico publicado en 2020

Diverse Protein Profiles in CNS Myeloid Cells and CNS Tissue From Lipopolysaccharide- and Vehicle-Injected APP/PS1 Transgenic Mice Implicate Cathepsin Z in Alzheimer's Disease

artículo científico publicado en 2018

Early detection of cerebral glucose uptake changes in the 5XFAD mouse

artículo científico publicado en 2014

Enantiomer effects of huperzine A on the aryl acylamidase activity of human cholinesterases ⬇️

artículo científico publicado el 1 de febrero de 2003

Evidence for Cholinergic Dysfunction in Autosomal Dominant Kufs Disease

artículo científico publicado en 2018

Hippocampal volume is associated with memory but not monmemory cognitive performance in patients with mild cognitive impairment.

artículo científico publicado en 2003

Homocysteine thiolactone and human cholinesterases

artículo científico publicado en 2006

Human serum cholinesterase from liver pathological samples exhibit highly elevated aryl acylamidase activity

scientific article published on 11 February 2007

Imaging Butyrylcholinesterase in Multiple Sclerosis

artículo científico publicado en 2020

Improved prediction of early-onset coronary artery disease using APOE epsilon4, BChE-K, PPARgamma2 Pro12 and ENOS T-786C in a polygenic model

scientific article published on 18 November 2005

Information processing and magnetic resonance imaging indices of brain pathology in multiple sclerosis.

artículo científico publicado en 2012

Inhibition of human cholinesterases by drugs used to treat Alzheimer disease

artículo científico publicado en 2003

Kinetic analysis of butyrylcholinesterase-catalyzed hydrolysis of acetanilides

scientific article published on 30 June 2007

Limitations of conventional inhibitor classifications

artículo científico publicado en 2011

Lipid-lowering agents and the risk of cognitive impairment that does not meet criteria for dementia, in relation to apolipoprotein E status

artículo científico publicado en 2007

Neurobiology of butyrylcholinesterase.

artículo científico publicado en 2003

Neuropathological burden and the degree of frailty in relation to global cognition and dementia

artículo científico publicado en 2020

Neuropathology and cholinesterase expression in the brains of octogenarians and older

artículo científico publicado en 2022

On the active site for hydrolysis of aryl amides and choline esters by human cholinesterases

artículo científico publicado en 2006

Peripheral dysgraphia: dissociations of lowercase from uppercase letters and of print from cursive writing

artículo científico publicado en 2014

Potentially procholinergic effects of medications commonly used in older adults.

artículo científico publicado en 2011

Probing the Peripheral Site of Human Butyrylcholinesterase ⬇️

artículo científico publicado el 27 de agosto de 2012

Quantification of Butyrylcholinesterase Activity as a Sensitive and Specific Biomarker of Alzheimer's Disease

artículo científico publicado en 2017

Reduced Serotonin Transporter Levels and Inflammation in the Midbrain Raphe of 12 month old APPswe/PSEN1dE9 Mice

artículo científico publicado en 2017

Reduced fibrillar β-amyloid in subcortical structures in a butyrylcholinesterase-knockout Alzheimer disease mouse model

artículo científico publicado en 2016

Relation between butyrylcholinesterase K variant, paraoxonase 1 (PON1) Q and R and apolipoprotein E epsilon 4 genes in early-onset coronary artery disease.

artículo científico publicado en 2002

Retrospective Diagnosis of Dementia Using an Informant Interview Based on the Brief Cognitive Rating Scale ⬇️

artículo científico publicado el 1 de marzo de 1998

Selective reversible inhibition of human butyrylcholinesterase by aryl amide derivatives of phenothiazine.

artículo científico publicado en 2007

Selectivity of phenothiazine cholinesterase inhibitors for neurotransmitter systems

artículo científico publicado en 2013

Sensitivity of butyrylcholinesterase knockout mice to (--)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmis

artículo científico publicado en 2006

Spectrum of disease in vascular cognitive impairment.

artículo científico publicado en 1999

Structure-activity relationships for inhibition of human cholinesterases by alkyl amide phenothiazine derivatives.

artículo científico publicado en 2005

Synergistic inhibition of butyrylcholinesterase by galantamine and citalopram.

artículo científico publicado en 2011

Synthesis and Preliminary Evaluation of Phenyl 4-123I-Iodophenylcarbamate for Visualization of Cholinesterases Associated with Alzheimer Disease Pathology

artículo científico publicado en 2015

Synthesis and preliminary evaluation of piperidinyl and pyrrolidinyl iodobenzoates as imaging agents for butyrylcholinesterase

artículo científico publicado en 2011

Targeting butyrylcholinesterase for preclinical single photon emission computed tomography (SPECT) imaging of Alzheimer's disease.

artículo científico publicado en 2017

Tauopathy in the APPswe/PS1ΔE9 mouse model of familial Alzheimer's disease

scholarly article published 31 August 2018

The Toronto Cognitive Assessment (TorCA): normative data and validation to detect amnestic mild cognitive impairment

article

The cholinergic system in the basal forebrain of the Atlantic white-sided dolphin (Lagenorhynchus acutus)

artículo científico publicado en 2018

The risk of dementia in relation to statins and other lipid lowering agents.

artículo científico publicado en 2003

Thioesters for the in vitro evaluation of agents to image brain cholinesterases.

artículo científico publicado en 2012

Tomographic visualization of cholinesterase.

artículo científico publicado en 2006

Lista de obras de Sultan Darvesh

1-(3-<i>Tert</i>-Butylphenyl)-2,2,2-Trifluoroethanone as a Potent Transition-State Analogue Slow-Binding Inhibitor of Human Acetylcholinesterase: Kinetic, MD and QM/MM Studies

A medical health report on individuals with silent butyrylcholinesterase in the Vysya community of India

A method to describe enzyme-catalyzed reactions by combining steady state and time course enzyme kinetic parameters

A versatile equation to describe reversible enzyme inhibition and activation kinetics: modeling beta-galactosidase and butyrylcholinesterase

An MRI brain atrophy and lesion index to assess the progression of structural changes in Alzheimer's disease, mild cognitive impairment, and normal aging: a follow-up study.

An MRI-based semiquantitative index for the evaluation of brain atrophy and lesions in Alzheimer's disease, mild cognitive impairment and normal aging

An integrated proteomics approach shows synaptic plasticity changes in an APP/PS1 Alzheimer's mouse model

Aryl acylamidase activity of human serum albumin with o-nitrotrifluoroacetanilide as the substrate

Butyrylcholinesterase Is Associated With β-Amyloid Plaques in the Transgenic APPSWE/PSEN1dE9 Mouse Model of Alzheimer Disease ⬇️

Butyrylcholinesterase activity in multiple sclerosis neuropathology.

Butyrylcholinesterase and the cholinergic system.

Butyrylcholinesterase as a Diagnostic and Therapeutic Target for Alzheimer's Disease

Butyrylcholinesterase radioligands to image Alzheimer's disease brain.

Butyrylcholinesterase-Mediated enhancement of the enzymatic activity of trypsin

Butyrylcholinesterase-knockout reduces brain deposition of fibrillar β-amyloid in an Alzheimer mouse model.

Butyrylcholinesterase-knockout reduces fibrillar β-amyloid and conserves 18FDG retention in 5XFAD mouse model of Alzheimer's disease

Carbamates with differential mechanism of inhibition toward acetylcholinesterase and butyrylcholinesterase.

Cholinergic Neurons in Nucleus Subputaminalis in Primary Progressive Aphasia

Cholinesterase inhibition in Alzheimer's disease: is specificity the answer?

Cholinesterase inhibitors modify the activity of intrinsic cardiac neurons.

Cholinesterases in cardiac ganglia and modulation of canine intrinsic cardiac neuronal activity

Cholinesterases in normal and Alzheimer's disease primary olfactory gyrus.

Cholinesterases: roles in the brain during health and disease.

Clock Drawing Test in acute stroke and its relationship with long-term functional and cognitive outcomes

Comparison of the Binding of Reversible Inhibitors to Human Butyrylcholinesterase and Acetylcholinesterase: A Crystallographic, Kinetic and Calorimetric Study.

Corticobasal degeneration substantiated by imaging studies.

Cysteine thioesters as myelin proteolipid protein analogues to examine the role of butyrylcholinesterase in myelin decompaction.

Development of acetophenone ligands as potential neuroimaging agents for cholinesterases.

Differential binding of phenothiazine urea derivatives to wild-type human cholinesterases and butyrylcholinesterase mutants.

Differential effects of lipid-lowering agents on human cholinesterases.

Disconnection of language and memory in semantic dementia: a comparative and theoretical analysis

Distribution of Acetylcholinesterase in the Hippocampal Formation of the Atlantic White-sided Dolphin (Lagenorhynchus acutus)

Diverse Protein Profiles in CNS Myeloid Cells and CNS Tissue From Lipopolysaccharide- and Vehicle-Injected APP/PS1 Transgenic Mice Implicate Cathepsin Z in Alzheimer's Disease

Early detection of cerebral glucose uptake changes in the 5XFAD mouse

Enantiomer effects of huperzine A on the aryl acylamidase activity of human cholinesterases ⬇️

Evidence for Cholinergic Dysfunction in Autosomal Dominant Kufs Disease

Hippocampal volume is associated with memory but not monmemory cognitive performance in patients with mild cognitive impairment.

Homocysteine thiolactone and human cholinesterases

Human serum cholinesterase from liver pathological samples exhibit highly elevated aryl acylamidase activity

Imaging Butyrylcholinesterase in Multiple Sclerosis

Improved prediction of early-onset coronary artery disease using APOE epsilon4, BChE-K, PPARgamma2 Pro12 and ENOS T-786C in a polygenic model

Information processing and magnetic resonance imaging indices of brain pathology in multiple sclerosis.

Inhibition of human cholinesterases by drugs used to treat Alzheimer disease

Kinetic analysis of butyrylcholinesterase-catalyzed hydrolysis of acetanilides

Limitations of conventional inhibitor classifications

Lipid-lowering agents and the risk of cognitive impairment that does not meet criteria for dementia, in relation to apolipoprotein E status

Neurobiology of butyrylcholinesterase.

Neuropathological burden and the degree of frailty in relation to global cognition and dementia

Neuropathology and cholinesterase expression in the brains of octogenarians and older

On the active site for hydrolysis of aryl amides and choline esters by human cholinesterases

Peripheral dysgraphia: dissociations of lowercase from uppercase letters and of print from cursive writing

Potentially procholinergic effects of medications commonly used in older adults.

Probing the Peripheral Site of Human Butyrylcholinesterase ⬇️

Quantification of Butyrylcholinesterase Activity as a Sensitive and Specific Biomarker of Alzheimer's Disease

Reduced Serotonin Transporter Levels and Inflammation in the Midbrain Raphe of 12 month old APPswe/PSEN1dE9 Mice

Reduced fibrillar β-amyloid in subcortical structures in a butyrylcholinesterase-knockout Alzheimer disease mouse model

Relation between butyrylcholinesterase K variant, paraoxonase 1 (PON1) Q and R and apolipoprotein E epsilon 4 genes in early-onset coronary artery disease.

Retrospective Diagnosis of Dementia Using an Informant Interview Based on the Brief Cognitive Rating Scale ⬇️

Selective reversible inhibition of human butyrylcholinesterase by aryl amide derivatives of phenothiazine.

Selectivity of phenothiazine cholinesterase inhibitors for neurotransmitter systems

Sensitivity of butyrylcholinesterase knockout mice to (--)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmis

Spectrum of disease in vascular cognitive impairment.

Structure-activity relationships for inhibition of human cholinesterases by alkyl amide phenothiazine derivatives.

Synergistic inhibition of butyrylcholinesterase by galantamine and citalopram.

Synthesis and Preliminary Evaluation of Phenyl 4-123I-Iodophenylcarbamate for Visualization of Cholinesterases Associated with Alzheimer Disease Pathology

Synthesis and preliminary evaluation of piperidinyl and pyrrolidinyl iodobenzoates as imaging agents for butyrylcholinesterase

Targeting butyrylcholinesterase for preclinical single photon emission computed tomography (SPECT) imaging of Alzheimer's disease.

Tauopathy in the APPswe/PS1ΔE9 mouse model of familial Alzheimer's disease

The Toronto Cognitive Assessment (TorCA): normative data and validation to detect amnestic mild cognitive impairment

The cholinergic system in the basal forebrain of the Atlantic white-sided dolphin (Lagenorhynchus acutus)

The risk of dementia in relation to statins and other lipid lowering agents.

Thioesters for the in vitro evaluation of agents to image brain cholinesterases.

Tomographic visualization of cholinesterase.